Akari Therapeutics (AKTX) Cash from Operations Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 37.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 16.64% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.60% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 34.32% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.11% |
| Jun 30, 2025 | 27.58% |
| Mar 31, 2025 | 24.77% |
| Dec 31, 2024 | -25.99% |
| Sep 30, 2024 | 99.52% |
| Jun 30, 2024 | -0.19% |
| Mar 31, 2024 | 18.31% |
| Dec 31, 2023 | -25.99% |
| Sep 30, 2023 | 99.42% |
| Jun 30, 2023 | -25.99% |
| Mar 31, 2023 | 99.14% |
| Jun 30, 2022 | -21.56% |
| Mar 31, 2022 | -188.67% |
| Dec 31, 2021 | 14,172.64% |
| Sep 30, 2021 | -13,644.58% |
| Jun 30, 2021 | 16.25% |
| Mar 31, 2021 | -19.04% |
| Dec 31, 2020 | 11,329.58% |
| Sep 30, 2020 | -11,033.86% |
| Jun 30, 2020 | 11,709.93% |
| Mar 31, 2020 | -9,350.94% |
| Dec 31, 2019 | 18.90% |
| Sep 30, 2019 | 0.59% |
| Jun 30, 2019 | 5.70% |
| Mar 31, 2019 | 26.63% |
| Dec 31, 2018 | 11.07% |
| Sep 30, 2018 | -47.16% |
| Jun 30, 2018 | -128.15% |
| Mar 31, 2018 | -30.29% |
| Dec 31, 2017 | -133.62% |
| Sep 30, 2017 | -66.11% |
| Jun 30, 2017 | -26.38% |
| Mar 31, 2017 | -64.81% |